In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side ...

Among body composition measures, reductions in fat mass and lean mass due to maridebart cafraglutide treatment were 26.2% to 36.8% and 8.6% to 11.6%, respectively, among obese participants.

CagriSema led to a 20.4% weight loss at 68 weeks vs. 3.0% with placebo in adults without diabetes. 50.7% of CagriSema users with obesity reached a BMI under 30, compared to 10.2% in the placebo ...

Next-generation weight loss drugs may do more than shrink your waistline. A new study suggests that a medication in the same family as Ozempic could cut the number of days people suffer from ...

Doctors call the new weight-loss drugs revolutionary. Game-changing. Unprecedented. Soon, they may also call them obsolete. Drugmakers are racing to develop the next wave of obesity and diabetes ...

Get Instant Summarized Text (Gist) A comprehensive weight loss program combining diet, exercise, counseling, and GLP-1 agonist injections enabled obese end-stage kidney disease patients to achieve ...

Academics at King's College London and the University of East Anglia have released guidance for GPs on how to manage patients who may be privately accessing weight loss drugs.

June 22 (Reuters) - Novo Nordisk , opens new tab on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that side effects were mainly mild-to ...